2025 · 3rd Quarter (July 1 - Sep 30)

ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION

Filed by EMERGENT STRATEGIES.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2025
Income: $15,000.00
Expenses: Not reported
Registrant: EMERGENT STRATEGIES
Client: ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION
Filing UUID: 0e438eeb-1e39-43c8-af41-d0e25433f17d
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MED · Medical/Disease Research/Clinical Labs

Health tax issues and trade Issues related to Small Business Innovation Research Program PAHPA Reauthorization

TAX · Taxation/Internal Revenue Code

Issues relating to health tax issues and trade

CPI · Computer Industry

Issues related to health data privacy

TRD · Trade (domestic/foreign)

Issues related to CHIPS implementation and critical supply chains

MMM · Medicare/Medicaid

Issues on legislation pertaining to S.1717 Ensuring Patient Access to Critical Breakthrough Products Act of 2025 Issues related to transitional coverage of emerging technologies

Literal federal measure citations: S.1717

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.